[DIYbio] White House OSTP requests comments on changes to Coordinated Framework

5:54 PM |

Hello,

Earlier this year the White House asked EPA, USDA and FDA to review the Coordinated Framework on Biotechnology. Yesterday the White House Office of Science and Technology opened comments from the public on their process to make changes. This is the first review of the Coordinated Framework since 1992 so it may be a while till it's reviewed again, it's therefore very important for the DIY Bio community to engage with the process. You can bet big companies and anti-GMO activists are heavily involved in this process and most of them would like less DIY Bio. This comment process is one way for our voices to be heard. Link to submit comments is below.

They have specifically requested comments on the following five questions, but you can submit any kind of comment you want. The more thought out and supported by data the better. Case studies for examples where DIY Bio has been helped or hindered by regulation will be particularly helpful. OSTP seeks answers to these questions:

  1. What additional clarification could be provided regarding which biotechnology product areas are within the statutory authority and responsibility of each agency?

  2. What additional clarification could be provided regarding the roles that each agency plays for different biotechnology product areas, particularly for those product areas that fall within the responsibility of multiple agencies, and how those roles relate to each other in the course of a regulatory assessment?

  3. How can Federal agencies improve their communication to consumers, industry, and other stakeholders regarding the authorities, practices, and bases for decision-making used to ensure the safety of the products of biotechnology?

  4. Are there relevant data and information, including case studies, that can inform the update to the CF or the development of the long-term strategy regarding how to improve the transparency, coordination, predictability, and efficiency of the regulatory system for the products of biotechnology?

  5. Are there specific issues that should be addressed in the update of the CF or in the long-term strategy in order to increase the transparency, coordination, predictability, and efficiency of the regulatory system for the products of biotechnology?


Regards,
Antony

--
-- You received this message because you are subscribed to the Google Groups DIYbio group. To post to this group, send email to diybio@googlegroups.com. To unsubscribe from this group, send email to diybio+unsubscribe@googlegroups.com. For more options, visit this group at https://groups.google.com/d/forum/diybio?hl=en
Learn more at www.diybio.org
---
You received this message because you are subscribed to the Google Groups "DIYbio" group.
To unsubscribe from this group and stop receiving emails from it, send an email to diybio+unsubscribe@googlegroups.com.
To post to this group, send email to diybio@googlegroups.com.
Visit this group at http://groups.google.com/group/diybio.
To view this discussion on the web visit https://groups.google.com/d/msgid/diybio/11381787-dbca-41fe-bc51-91f52d476135%40googlegroups.com.
For more options, visit https://groups.google.com/d/optout.

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • RSS
Posted by Science

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)